SNIPR - A CRISPR Company Employee Directory
Biotechnology ResearchHovedstaden, Denmark11-50 Employees
SNIPR Biome Aps is a Copenhagen-based biotechnology company developing therapies for antibiotic-resistant bacterial infections, employing CRISPR-enabled approaches to create new treatment options. It operates within the biotechnology research sector, aiming to deliver next-generation medicines for infections that no longer respond to conventional antibiotics. The company is a small to mid-sized organization typical of early-stage bioscience ventures. Its work focuses on translating genetic technologies into therapeutic strategies that target resistant bacteria while minimizing effects on the host. Based in the Copenhagen region of Denmark, SNIPR Biome is pursuing a phage cocktail to treat Pseudomonas infections in the lungs, including chronic infections associated with cystic fibrosis. This program reflects the company’s focus on antimicrobial-resistance research and the development of therapies that complement traditional antibiotics.